Executable network of SARS-CoV-2-host interaction predicts drug combination treatments

The COVID-19 pandemic has pushed healthcare systems globally to a breaking point. The urgent need for effective and affordable COVID-19 treatments calls for repurposing combinations of approved drugs. The challenge is to identify which combinations are likely to be most effective and at what stages...

Descripción completa

Detalles Bibliográficos
Autores principales: Howell, Rowan, Clarke, Matthew A., Reuschl, Ann-Kathrin, Chen, Tianyi, Abbott-Imboden, Sean, Singer, Mervyn, Lowe, David M., Bennett, Clare L., Chain, Benjamin, Jolly, Clare, Fisher, Jasmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844383/
https://www.ncbi.nlm.nih.gov/pubmed/35165389
http://dx.doi.org/10.1038/s41746-022-00561-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844383/
https://www.ncbi.nlm.nih.gov/pubmed/35165389
http://dx.doi.org/10.1038/s41746-022-00561-5

Ejemplares similares